GH Research’s losses persist as it tries to lift FDA hold for GH001

Green Market Report
By Adam JacksonSep 3, 2024, 8:30 am155 ptsTop
Clinical-stage GH Research PLC (Nasdaq: GHRS) reported a wider second-quarter loss Tuesday as it pushes forward with its experimental depression treatment trials. The Dublin-based company lost $10.4 million in the quarter ending June 30. That compares with a loss of $7.7 million a year earlier. The higher net…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Marijuana operator Gold Flora facing receivership amid financial challenges 69

LeafLink buys online wholesale competitor Leaf Trade 68

Kentucky issues medical marijuana permits amid out-of-state controversy 67

Teens in Danger: How Marijuana Legalization is Fueling a Youth Addiction Crisis 66

Cannabis company Canopy Growth appoints Luc Mongeau as CEO 65

Cannabis wholesale platform LeafLink buys Leaf Trade 65

What to expect from next week’s cannabis rescheduling hearing 63

POSaBIT reports third-quarter loss despite payment platform growth 62

About NewsBudz

NewsBudz is a marijuana and medical cannabis news app. The site delivers a daily feed of the latest cannabis news. We aggregate over 30 of the web's best sources for news about marijuana, hemp and legalization to keep you informed.

Stay on top of the latest news headlines, trends and developments worldwide around recreational and medical marijuana. Sit back and relax, while you read learn and share. On the web or your mobile device, NewsBudz is your cannabis news stream.